LISA WILLIAMS: Open Payments
NPI 1235295676 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$565 in 29 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $565
Food & beverage: $565
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $109 |
| Lilly USA, LLC | 4 | $79 |
| Astellas Pharma US Inc | 4 | $78 |
| Dexcom, Inc. | 3 | $56 |
| Optinose US, Inc. | 2 | $50 |
| PFIZER INC. | 2 | $41 |
| Novo Nordisk Inc | 2 | $36 |
| Inspire Medical Systems, Inc. | 1 | $30 |
| KYOWA KIRIN, INC. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
Products named: AIRSUPRA, MOUNJARO, Veozah, Dexcom G6 Transmitter, Xhance, PREVNAR 20, INSPIRE, FARXIGA.
Industry payments across TX — which companies pay providers there.
